This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carcamo, J.
Right arrow Articles by Massague, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carcamo, J.
Right arrow Articles by Massague, J.

 Previous Article  |  Next Article 

Mol. Cell. Biol., 03 1995, 1573-1581, Vol 15, No. 3
Copyright © 1995, American Society for Microbiology

Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex

J Carcamo, A Zentella and J Massague
Cell Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center, New York, New York 10021.

T beta R-II (transforming growth factor beta [TGF-beta] type II receptor) is a transmembrane serine/threonine kinase that acts as the primary TGF-beta receptor. Ligand binding to T beta R-II leads to the recruitment and phosphorylation of T beta R-I, a distantly related transmembrane kinase that acts as a downstream signaling component. T beta R-I phosphorylation by T beta R-II is shown here to be essential for signaling. A mutant T beta R-II that binds ligand but lacks signaling activity was identified. This mutant was identified by screening with a TGF-beta-inducible vector a series of mink lung epithelial cell clones that have normal TGF-beta binding activity but have lost antiproliferative and transcriptional responses to TGF-beta. When transiently cotransfected with T beta R-II, one of these cell lines, S-21, recovered TGF-beta responsiveness. cDNA cloning and sequencing of T beta R-II from S-21 cells revealed a point mutation that changes proline 525 to leucine in kinase subdomain XI. A recombinant receptor containing this mutation, T beta R-II(P525L), is similar to wild-type T beta R-II in its abilities to bind ligand, support ligand binding to T beta R-I, and form a complex with T beta R- I in vivo. T beta R-II(P525L) has autophosphorylating activity in vitro and in vivo; however, unlike the wild-type receptor, it fails to phosphorylate an associated T beta R-I.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:

  • Belville, C., Marechal, J.-D., Pennetier, S., Carmillo, P., Masgrau, L., Messika-Zeitoun, L., Galey, J., Machado, G., Treton, D., Gonzales, J., Picard, J.-Y., Josso, N., Cate, R. L., di Clemente, N. (2009). Natural mutations of the anti-Mullerian hormone type II receptor found in persistent Mullerian duct syndrome affect ligand binding, signal transduction and cellular transport. Hum Mol Genet 18: 3002-3013 [Abstract] [Full Text]  
  • Zeng, Q., Phukan, S., Xu, Y., Sadim, M., Rosman, D. S., Pennison, M., Liao, J., Yang, G.-Y., Huang, C.-C., Valle, L., Di Cristofano, A., de la Chapelle, A., Pasche, B. (2009). Tgfbr1 Haploinsufficiency Is a Potent Modifier of Colorectal Cancer Development. Cancer Res. 69: 678-686 [Abstract] [Full Text]  
  • Shin, D.-M., Jeon, J.-H., Kim, C.-W., Cho, S.-Y., Lee, H.-J., Jang, G.-Y., Jeong, E. M., Lee, D.-S., Kang, J.-H., Melino, G., Park, S.-C., Kim, I.-G. (2008). TGF{beta} mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. FASEB J. 22: 2498-2507 [Abstract] [Full Text]  
  • Rosman, D. S., Phukan, S., Huang, C.-C., Pasche, B. (2008). TGFBR1*6A Enhances the Migration and Invasion of MCF-7 Breast Cancer Cells through RhoA Activation. Cancer Res. 68: 1319-1328 [Abstract] [Full Text]  
  • You, H. J., Bruinsma, M. W., How, T., Ostrander, J. H., Blobe, G. C. (2007). The type III TGF- receptor signals through both Smad3 and the p38 MAP kinase pathways to contribute to inhibition of cell proliferation. Carcinogenesis 28: 2491-2500 [Abstract] [Full Text]  
  • Casey, T. M., Mulvey, T. M., Patnode, T. A., Dean, A., Zakrzewska, E., Plaut, K. (2007). Mammary Epithelial Cells Treated Concurrently with TGF-{alpha} and TGF-{beta} Exhibit Enhanced Proliferation and Death. Exp. Biol. Med. 232: 1027-1040 [Abstract] [Full Text]  
  • Jing, Z.-C., Xu, X.-Q., Han, Z.-Y., Wu, Y., Deng, K.-W., Wang, H., Wang, Z.-W., Cheng, X.-S., Xu, B., Hu, S.-S., Hui, R.-T., Yang, Y.-J. (2007). Registry and Survival Study in Chinese Patients With Idiopathic and Familial Pulmonary Arterial Hypertension. Chest 132: 373-379 [Abstract] [Full Text]  
  • Yang, H.-Y., Cheng, C.-F., Djoko, B., Lian, W.-S., Tu, C.-F., Tsai, M.-T., Chen, Y.-H., Chen, C.-C., Cheng, C.-J., Yang, R.-B. (2007). Transgenic overexpression of the secreted, extracellular EGF-CUB domain-containing protein SCUBE3 induces cardiac hypertrophy in mice. Cardiovasc Res 75: 139-147 [Abstract] [Full Text]  
  • Van Themsche, C., Mathieu, I., Parent, S., Asselin, E. (2007). Transforming Growth Factor-beta3 Increases the Invasiveness of Endometrial Carcinoma Cells through Phosphatidylinositol 3-Kinase-dependent Up-regulation of X-linked Inhibitor of Apoptosis and Protein Kinase C-dependent Induction of Matrix Metalloproteinase-9. J. Biol. Chem. 282: 4794-4802 [Abstract] [Full Text]  
  • Sun, Y., Ding, L., Zhang, H., Han, J., Yang, X., Yan, J., Zhu, Y., Li, J., Song, H., Ye, Q. (2006). Potentiation of Smad-mediated transcriptional activation by the RNA-binding protein RBPMS. Nucleic Acids Res 34: 6314-6326 [Abstract] [Full Text]  
  • Gomis, R. R., Alarcon, C., He, W., Wang, Q., Seoane, J., Lash, A., Massague, J. (2006). A FoxO-Smad synexpression group in human keratinocytes. Proc. Natl. Acad. Sci. USA 103: 12747-12752 [Abstract] [Full Text]  
  • Kollias, H. D., Perry, R. L. S., Miyake, T., Aziz, A., McDermott, J. C. (2006). Smad7 promotes and enhances skeletal muscle differentiation.. Mol. Cell. Biol. 26: 6248-6260 [Abstract] [Full Text]  
  • Jinnin, M., Ihn, H., Tamaki, K. (2006). Characterization of SIS3, a Novel Specific Inhibitor of Smad3, and Its Effect on Transforming Growth Factor-beta1-Induced Extracellular Matrix Expression. Mol. Pharmacol. 69: 597-607 [Abstract] [Full Text]  
  • Huang, S. A., Mulcahey, M. A., Crescenzi, A., Chung, M., Kim, B. W., Barnes, C., Kuijt, W., Turano, H., Harney, J., Larsen, P. R. (2005). Transforming Growth Factor-{beta} Promotes Inactivation of Extracellular Thyroid Hormones via Transcriptional Stimulation of Type 3 Iodothyronine Deiodinase. Mol. Endocrinol. 19: 3126-3136 [Abstract] [Full Text]  
  • Pannu, H., Fadulu, V. T., Chang, J., Lafont, A., Hasham, S. N., Sparks, E., Giampietro, P. F., Zaleski, C., Estrera, A. L., Safi, H. J., Shete, S., Willing, M. C., Raman, C.S., Milewicz, D. M. (2005). Mutations in Transforming Growth Factor-{beta} Receptor Type II Cause Familial Thoracic Aortic Aneurysms and Dissections. Circulation 112: 513-520 [Abstract] [Full Text]  
  • Munoz-Sanjuan, I., Brivanlou, A. H. (2005). Induction of Ectopic Olfactory Structures and Bone Morphogenetic Protein Inhibition by Rossy, a Group XII Secreted Phospholipase A2. Mol. Cell. Biol. 25: 3608-3619 [Abstract] [Full Text]  
  • Daniels, M., Shimizu, K., Zorn, A. M., Ohnuma, S.-i. (2004). Negative regulation of Smad2 by PIASy is required for proper Xenopus mesoderm formation. Development 131: 5613-5626 [Abstract] [Full Text]  
  • Zhao, M., Qiao, M., Harris, S. E., Oyajobi, B. O., Mundy, G. R., Chen, D. (2004). Smurf1 Inhibits Osteoblast Differentiation and Bone Formation in Vitro and in Vivo. J. Biol. Chem. 279: 12854-12859 [Abstract] [Full Text]  
  • Hyman, C. A., Bartholin, L., Newfeld, S. J., Wotton, D. (2003). Drosophila TGIF Proteins Are Transcriptional Activators. Mol. Cell. Biol. 23: 9262-9274 [Abstract] [Full Text]  
  • Siegel, P. M., Shu, W., Massague, J. (2003). Mad Upregulation and Id2 Repression Accompany Transforming Growth Factor (TGF)-{beta}-mediated Epithelial Cell Growth Suppression. J. Biol. Chem. 278: 35444-35450 [Abstract] [Full Text]  
  • Imoto, S., Sugiyama, K., Muromoto, R., Sato, N., Yamamoto, T., Matsuda, T. (2003). Regulation of Transforming Growth Factor-{beta} Signaling by Protein Inhibitor of Activated STAT, PIASy through Smad3. J. Biol. Chem. 278: 34253-34258 [Abstract] [Full Text]  
  • Siegel, P. M., Shu, W., Cardiff, R. D., Muller, W. J., Massague, J. (2003). Transforming growth factor {beta} signaling impairs Neu-induced mammary tumorigenesis while promoting pulmonary metastasis. Proc. Natl. Acad. Sci. USA 100: 8430-8435 [Abstract] [Full Text]  
  • Plaut, K., Dean, A. J., Patnode, T. A., Casey, T. M. (2003). Effect of Transforming Growth Factor-beta (TGF-{beta}) on Mammary Development. J DAIRY SCI 86: E16-27 [Abstract] [Full Text]  
  • Gray, P. C., Harrison, C. A., Vale, W. (2003). Cripto forms a complex with activin and type II activin receptors and can block activin signaling. Proc. Natl. Acad. Sci. USA 100: 5193-5198 [Abstract] [Full Text]  
  • Langley, B., Thomas, M., Bishop, A., Sharma, M., Gilmour, S., Kambadur, R. (2002). Myostatin Inhibits Myoblast Differentiation by Down-regulating MyoD Expression. J. Biol. Chem. 277: 49831-49840 [Abstract] [Full Text]  
  • Bourguignon, L. Y. W., Singleton, P. A., Zhu, H., Zhou, B. (2002). Hyaluronan Promotes Signaling Interaction between CD44 and the Transforming Growth Factor beta Receptor I in Metastatic Breast Tumor Cells. J. Biol. Chem. 277: 39703-39712 [Abstract] [Full Text]  
  • Danila, D. C., Zhang, X., Zhou, Y., Haidar, J. N. S., Klibanski, A. (2002). Overexpression of Wild-Type Activin Receptor Alk4-1 Restores Activin Antiproliferative Effects in Human Pituitary Tumor Cells. J. Clin. Endocrinol. Metab. 87: 4741-4746 [Abstract] [Full Text]  
  • Chen, A., Davis, B. H., Sitrin, M. D., Brasitus, T. A., Bissonnette, M. (2002). Transforming growth factor-beta 1 signaling contributes to Caco-2 cell growth inhibition induced by 1,25(OH)2D3. Am. J. Physiol. Gastrointest. Liver Physiol. 283: G864-G874 [Abstract] [Full Text]  
  • Suganuma, T., Kawabata, M., Ohshima, T., Ikeda, M.-A. (2002). Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator. Proc. Natl. Acad. Sci. USA 99: 13073-13078 [Abstract] [Full Text]  
  • Yan, Y.-T., Liu, J.-J., Luo, Y., E, C., Haltiwanger, R. S., Abate-Shen, C., Shen, M. M. (2002). Dual Roles of Cripto as a Ligand and Coreceptor in the Nodal Signaling Pathway. Mol. Cell. Biol. 22: 4439-4449 [Abstract] [Full Text]  
  • Bollard, C. M., Rossig, C., Calonge, M. J., Huls, M. H., Wagner, H.-J., Massague, J., Brenner, M. K., Heslop, H. E., Rooney, C. M. (2002). Adapting a transforming growth factor beta -related tumor protection strategy to enhance antitumor immunity. Blood 99: 3179-3187 [Abstract] [Full Text]  
  • Dunfield, L. D., Dwyer, E. J. C., Nachtigal, M. W. (2002). TGF{beta}-Induced Smad Signaling Remains Intact in Primary Human Ovarian Cancer Cells. Endocrinology 143: 1174-1181 [Abstract] [Full Text]  
  • Eickelberg, O., Centrella, M., Reiss, M., Kashgarian, M., Wells, R. G. (2002). Betaglycan Inhibits TGF-beta Signaling by Preventing Type I-Type II Receptor Complex Formation. GLYCOSAMINOGLYCAN MODIFICATIONS ALTER BETAGLYCAN FUNCTION. J. Biol. Chem. 277: 823-829 [Abstract] [Full Text]  
  • Liu, D., Black, B. L., Derynck, R. (2001). TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3. Genes Dev. 15: 2950-2966 [Abstract] [Full Text]  
  • Matsuda, T., Yamamoto, T., Muraguchi, A., Saatcioglu, F. (2001). Cross-talk between Transforming Growth Factor-beta and Estrogen Receptor Signaling through Smad3. J. Biol. Chem. 276: 42908-42914 [Abstract] [Full Text]  
  • Messika-Zeitoun, L., Gouedard, L., Belville, C., Dutertre, M., Lins, L., Imbeaud, S., Hughes, I. A., Picard, J.-Y., Josso, N., di Clemente, N. (2001). Autosomal Recessive Segregation of a Truncating Mutation of Anti-Mullerian Type II Receptor in a Family Affected by the Persistent Mullerian Duct Syndrome Contrasts with Its Dominant Negative Activity in Vitro. J. Clin. Endocrinol. Metab. 86: 4390-4397 [Abstract] [Full Text]  
  • Ji, C., Eickelberg, O., McCarthy, T. L., Centrella, M. (2001). Control and Counter-Control of TGF-{beta} Activity through FAST and Runx (CBFa) Transcriptional Elements in Osteoblasts. Endocrinology 142: 3873-3879 [Abstract] [Full Text]  
  • Garamszegi, N., Dore, J. J. E. Jr., Penheiter, S. G., Edens, M., Yao, D., Leof, E. B. (2001). Transforming Growth Factor beta Receptor Signaling and Endocytosis Are Linked through a COOH Terminal Activation Motif in the Type I Receptor. Mol. Biol. Cell 12: 2881-2893 [Abstract] [Full Text]  
  • Loscalzo, J. (2001). Genetic Clues to the Cause of Primary Pulmonary Hypertension. NEJM 345: 367-371 [Full Text]  
  • Furuhashi, M., Yagi, K., Yamamoto, H., Furukawa, Y., Shimada, S., Nakamura, Y., Kikuchi, A., Miyazono, K., Kato, M. (2001). Axin Facilitates Smad3 Activation in the Transforming Growth Factor {beta} Signaling Pathway. Mol. Cell. Biol. 21: 5132-5141 [Abstract] [Full Text]  
  • Auersperg, N., Wong, A. S. T., Choi, K.-C., Kang, S. K., Leung, P. C. K. (2001). Ovarian Surface Epithelium: Biology, Endocrinology, and Pathology. Endocr. Rev. 22: 255-288 [Abstract] [Full Text]  
  • Lücke, C. D., Philpott, A., Metcalfe, J. C., Thompson, A. M., Hughes-Davies, L., Kemp, P. R., Hesketh, R. (2001). Inhibiting Mutations in the Transforming Growth Factor {beta} Type 2 Receptor in Recurrent Human Breast Cancer. Cancer Res. 61: 482-485 [Abstract] [Full Text]  
  • Zhou, Y., Sun, H., Danila, D. C., Johnson, S. R., Sigai, D. P., Zhang, X., Klibanski, A. (2000). Truncated Activin Type I Receptor Alk4 Isoforms Are Dominant Negative Receptors Inhibiting Activin Signaling. Mol. Endocrinol. 14: 2066-2075 [Abstract] [Full Text]  
  • Yao, D., Dore, J. J. E. Jr., Leof, E. B. (2000). FKBP12 Is a Negative Regulator of Transforming Growth Factor-beta Receptor Internalization. J. Biol. Chem. 275: 13149-13154 [Abstract] [Full Text]  
  • Calonge, M. J., Massague, J. (1999). Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-beta Antiproliferative Responses in Colon Cancer Cells. J. Biol. Chem. 274: 33637-33643 [Abstract] [Full Text]  
  • Zhu, H.-J., Iaria, J., Sizeland, A. M. (1999). Smad7 Differentially Regulates Transforming Growth Factor beta -mediated Signaling Pathways. J. Biol. Chem. 274: 32258-32264 [Abstract] [Full Text]  
  • Pasche, B., Kolachana, P., Nafa, K., Satagopan, J., Chen, Y.-G., Lo, R. S., Brener, D., Yang, D., Kirstein, L., Oddoux, C., Ostrer, H., Vineis, P., Varesco, L., Jhanwar, S., Luzzatto, L., Massague, J., Offit, K. (1999). T{{beta}}R-I(6A) Is a Candidate Tumor Susceptibility Allele. Cancer Res. 59: 5678-5682 [Abstract] [Full Text]  
  • Sun, Y., Liu, X., Ng-Eaton, E., Lodish, H. F., Weinberg, R. A. (1999). SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc. Natl. Acad. Sci. USA 96: 12442-12447 [Abstract] [Full Text]  
  • Schiemann, W. P., Pfeifer, W. M., Levi, E., Kadin, M. E., Lodish, H. F. (1999). A Deletion in the Gene for Transforming Growth Factor beta Type I Receptor Abolishes Growth Regulation by Transforming Growth Factor beta in a Cutaneous T-Cell Lymphoma. Blood 94: 2854-2861 [Abstract] [Full Text]  
  • Zhu, H.-J., Sizeland, A. M. (1999). Extracellular Domain of the Transforming Growth Factor-beta Receptor Negatively Regulates Ligand-independent Receptor Activation. J. Biol. Chem. 274: 29220-29227 [Abstract] [Full Text]  
  • Nishihara, A., Hanai, J.-i., Imamura, T., Miyazono, K., Kawabata, M. (1999). E1A Inhibits Transforming Growth Factor-beta Signaling through Binding to Smad Proteins. J. Biol. Chem. 274: 28716-28723 [Abstract] [Full Text]  
  • Park, H.-J., Galper, J. B. (1999). 3-Hydroxy-3-methylglutaryl CoA reductase inhibitors up-regulate transforming growth factor-beta signaling in cultured heart cells via inhibition of geranylgeranylation of RhoA GTPase. Proc. Natl. Acad. Sci. USA 96: 11525-11530 [Abstract] [Full Text]  
  • Go, C., Li, P., Wang, X.-J. (1999). Blocking Transforming Growth Factor {beta} Signaling in Transgenic Epidermis Accelerates Chemical Carcinogenesis: A Mechanism Associated with Increased Angiogenesis. Cancer Res. 59: 2861-2868 [Abstract] [Full Text]  
  • Zhu, H.-J., Sizeland, A. M. (1999). A Pivotal Role for the Transmembrane Domain in Transforming Growth Factor-{beta} Receptor Activation. J. Biol. Chem. 274: 11773-11781 [Abstract] [Full Text]  
  • Kretzschmar, M., Doody, J., Timokhina, I., Massagué, J. (1999). A mechanism of repression of TGFbeta / Smad signaling by oncogenic Ras. Genes Dev. 13: 804-816 [Abstract] [Full Text]  
  • Yagi, K., Goto, D., Hamamoto, T., Takenoshita, S., Kato, M., Miyazono, K. (1999). Alternatively Spliced Variant of Smad2 Lacking Exon 3. COMPARISON WITH WILD-TYPE Smad2 AND Smad3. J. Biol. Chem. 274: 703-709 [Abstract] [Full Text]  
  • Choi, M. E. (1999). Cloning and characterization of a naturally occurring soluble form of TGF-beta type I receptor. Am. J. Physiol. Renal Physiol. 276: F88-F95 [Abstract] [Full Text]  
  • Kurokawa, M., Mitani, K., Imai, Y., Ogawa, S., Yazaki, Y., Hirai, H. (1998). The t(3;21) Fusion Product, AML1/Evi-1, Interacts With Smad3 and Blocks Transforming Growth Factor-beta -Mediated Growth Inhibition of Myeloid Cells. Blood 92: 4003-4012 [Abstract] [Full Text]  
  • Delude, R. L., Yoshimura, A., Ingalls, R. R., Golenbock, D. T. (1998). Construction of a Lipopolysaccharide Reporter Cell Line and Its Use in Identifying Mutants Defective in Endotoxin, But Not TNF-{alpha}, Signal Transduction. J. Immunol. 161: 3001-3009 [Abstract] [Full Text]  
  • Anders, R. A., Dore Jr., J. J. E., Arline, S. L., Garamszegi, N., Leof, E. B. (1998). Differential Requirement for Type I and Type II Transforming Growth Factor beta  Receptor Kinase Activity in Ligand-mediated Receptor Endocytosis. J. Biol. Chem. 273: 23118-23125 [Abstract] [Full Text]  
  • Chen, Y.-G., Hata, A., Lo, R. S., Wotton, D., Shi, Y., Pavletich, N., Massagué, J. (1998). Determinants of specificity in TGF-beta signal transduction. Genes Dev. 12: 2144-2152 [Abstract] [Full Text]  
  • Souchelnytskyi, S., Tamaki, K., Engstrom, U., Wernstedt, C., ten Dijke, P., Heldin, C.-H. (1997). Phosphorylation of Ser465 and Ser467 in the C Terminus of Smad2 Mediates Interaction with Smad4 and Is Required for Transforming Growth Factor-beta Signaling. J. Biol. Chem. 272: 28107-28115 [Abstract] [Full Text]  
  • Persson, U., Souchelnytskyi, S., Franzen, P., Miyazono, K., ten Dijke, P., Heldin, C.-H. (1997). Transforming Growth Factor (TGF-beta )-specific Signaling by Chimeric TGF-beta Type II Receptor with Intracellular Domain of Activin Type IIB Receptor. J. Biol. Chem. 272: 21187-21194 [Abstract] [Full Text]  
  • Ji, C., Casinghino, S., McCarthy, T. L., Centrella, M. (1997). Multiple and Essential Sp1 Binding Sites in the Promoter for Transforming Growth Factor-beta Type I Receptor. J. Biol. Chem. 272: 21260-21267 [Abstract] [Full Text]  
  • Wells, R. G., Yankelev, H., Lin, H. Y., Lodish, H. F. (1997). Biosynthesis of the Type I and Type II TGF-beta Receptors. IMPLICATIONS FOR COMPLEX FORMATION. J. Biol. Chem. 272: 11444-11451 [Abstract] [Full Text]  
  • Kretzschmar, M, Liu, F, Hata, A, Doody, J, Massague, J (1997). The TGF-beta family mediator Smad1 is phosphorylated directly and activated functionally by the BMP receptor kinase.. Genes Dev. 11: 984-995 [Abstract]  
  • Giannini, G., Di Marcotullio, L., Zazzeroni, F., Alesse, E., Zani, M., T'Ang, A., Sorrentino, V., Screpanti, I., Frati, L., Gulino, A. (1997). 2-Aminopurine Unravels a Role for pRB in the Regulation of Gene Expression by Transforming Growth Factor beta. J. Biol. Chem. 272: 5313-5319 [Abstract] [Full Text]  
  • Alevizopoulos, A., Mermod, N. (1996). Antagonistic Regulation of a Proline-rich Transcription Factor by Transforming Growth Factor beta and Tumor Necrosis Factor alpha. J. Biol. Chem. 271: 29672-29681 [Abstract] [Full Text]  
  • Ariazi, E. A., Gould, M. N. (1996). Identifying Differential Gene Expression in Monoterpene-treated Mammary Carcinomas Using Subtractive Display. J. Biol. Chem. 271: 29286-29294 [Abstract] [Full Text]  
  • Anders, R. A., Leof, E. B. (1996). Chimeric Granulocyte/Macrophage Colony-stimulating Factor/Transforming Growth Factor-beta (TGF-beta ) Receptors Define a Model System for Investigating the Role of Homomeric and Heteromeric Receptors in TGF-beta Signaling. J. Biol. Chem. 271: 21758-21766 [Abstract] [Full Text]  
  • Nishitoh, H., Ichijo, H., Kimura, M., Matsumoto, T., Makishima, F., Yamaguchi, A., Yamashita, H., Enomoto, S., Miyazono, K. (1996). Identification of Type I and Type II Serine/Threonine Kinase Receptors for Growth/Differentiation Factor-5. J. Biol. Chem. 271: 21345-21352 [Abstract] [Full Text]  
  • Centrella, M., Ji, C., Casinghino, S., McCarthy, T. L. (1996). Rapid Flux in Transforming Growth Factor-beta Receptors on Bone Cells. J. Biol. Chem. 271: 18616-18622 [Abstract] [Full Text]  
  • Yamamoto, H., Ueno, H., Ooshima, A., Takeshita, A. (1996). Adenovirus-mediated Transfer of a Truncated Transforming Growth Factor-beta (TGF-beta ) Type II Receptor Completely and Specifically Abolishes Diverse Signaling by TGF-beta in Vascular Wall Cells in Primary Culture. J. Biol. Chem. 271: 16253-16259 [Abstract] [Full Text]  
  • Saitoh, M., Nishitoh, H., Amagasa, T., Miyazono, K., Takagi, M., Ichijo, H. (1996). Identification of Important Regions in the Cytoplasmic Juxtamembrane Domain of Type I Receptor That Separate Signaling Pathways of Transforming Growth Factor-beta. J. Biol. Chem. 271: 2769-2775 [Abstract] [Full Text]  
  • Fewell, J., Kuff, E. (1996). Intracellular redistribution of Ku immunoreactivity in response to cell-cell contact and growth modulating components in the medium. J. Cell Sci. 109: 1937-1946 [Abstract]  
  • Melhuish, T. A., Wotton, D. (2000). The Interaction of the Carboxyl Terminus-binding Protein with the Smad Corepressor TGIF Is Disrupted by a Holoprosencephaly Mutation in TGIF. J. Biol. Chem. 275: 39762-39766 [Abstract] [Full Text]  
  • Jornvall, H., Blokzijl, A., Dijke, P. t., Ibanez, C. F. (2001). The Orphan Receptor Serine/Threonine Kinase ALK7 Signals Arrest of Proliferation and Morphological Differentiation in a Neuronal Cell Line. J. Biol. Chem. 276: 5140-5146 [Abstract] [Full Text]  
  • Leong, G. M., Subramaniam, N., Figueroa, J., Flanagan, J. L., Hayman, M. J., Eisman, J. A., Kouzmenko, A. P. (2001). Ski-interacting Protein Interacts with Smad Proteins to Augment Transforming Growth Factor-beta -dependent Transcription. J. Biol. Chem. 276: 18243-18248 [Abstract] [Full Text]  
  • Reffey, S. B., Wurthner, J. U., Parks, W. T., Roberts, A. B., Duckett, C. S. (2001). X-linked Inhibitor of Apoptosis Protein Functions as a Cofactor in Transforming Growth Factor-beta Signaling. J. Biol. Chem. 276: 26542-26549 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»